The 10 Commandments of ESC’s New STEMI Guidelines

The authors have given an entertaining account of the most relevant points and differences between the new STEMI guidelines and the prior ones, from 2014. The article features 10 points resembling the ten commandments, which makes it easy to read, compared to the tedious task of reading the complete guidelines.

1) The emergency systems should help anticipate time from STEMI diagnosis to PCI-mediated reperfusion, to be able to choose the best reperfusion strategy. If ≤ 120 minutes, the patient should be referred directly to PCI; if longer, perform an immediate fibrinolysis (within 10 minutes after diagnosis) and transfer the patient to a PCI center.


Read also: New High Blood Pressure Guidelines”.


2) Cardiac arrest survivors with STEMI on post resuscitation ECG should receive primary PCI.  In cases with no STEMI but still suspected ischemic cause, perform an angiography within 2 hours, after quickly excluding non-coronary causes. 

 

3) Oxygen is recommended only for patients with arterial saturation <90%.

4) Primary PCI includes reperfusion within 90 minutes after diagnosis, using routine transradial approach and routine drug eluting stents (DES). Preload patients with aspirin and prasugrel/ticagrelor and anticoagulation with unfractionated heparin.


Read also: FOURIER: Evolocumab Found Beneficial for Patients with Peripheral Vascular Disease of Prior MI”.


5) Fibrinolysis should be done with a specific fibrin agent, aspirin and clopidogrel and anticoagulation with enoxaparin. In patients ≥75, tenecteplase dose should be adjusted, and loading clopidogrel. Even with successful reperfusion, routine angiography should be prescribed between 2 and 24 hours bolus of lytic.

6) Patients should be monitored at least 24 hours after reperfusion. Early ambulation and discharge are the best option for patients without complications.

7) One year of dual antiplatelet therapy (DAPT: aspirin plus prasugrel or ticagrelor) is the standard. In patients at high risk of bleeding, only 6 months DAPT may be considered, and continue with aspirin. Though controversial, in patients who tolerate one year DAPT presenting high ischemic risk, extending DAPT up to 3 years may be considered.


Read also: DACAB: Ticagrelor and Aspirin Improve Vein Graft Patency”.


8) High doses of statins should be prescribed early when the goal is LDL <70 mg/dl. If not met, additional lipid lowering therapy should be considered.

9) Patients with infarction and normal coronary arteries, commonly called MINOCA, as in Myocardial Infarction With no Obstructive Coronary Atherosclerosis, should receive additional diagnostic studies in order to identify the etiology and adapt therapy, which might differ from the typical STEMI therapy.

10) It is important to establish indicators and audit the clinical practice to improve outcomes in real life patients. This is the only way to reduce the gap between evidence-based recommendations and the daily practice.

Original title: ‘Ten Commandments’ of the 2017 ESC STEMI Guidelines.

Reference: Borja Ibanez y Stefan James. Eur Heart J. Volume 39, Issue 2, 7 January 2018, Pages 83.

30-01-2018-2017-ESC-Guidelines-for-the-management-of-STEMI-patients“]


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...